Bacteriophage Therapy Market Growth in Future Scope 2022-2028

Mrunal Nerkar

Bacteriophage Therapy Market Growth in Future Scope 2022-2028

Bacteriophages Therapy is a highly innovative form of complementary medicine. It is a treatment that involves the use of bacteria to heal the body. It can be effective in fighting viruses, infections, and diseases including influenza, viral arthritis, HIV, hepatitis, and cancer. In fact, studies have shown that when patients are treated with bacteriophages they have higher recovery rates and have lower complications than those who have remained untreated.

The recent past has witnessed an increased incidence of antimicrobial-resistance infection in patients. These antimicrobial-resistant infections are caused by bacteria such as Salmonella typhi, Mycobacterium tuberculosis, Pseudomonas aeruginosa, and others.

Increasing prevalence of such antimicrobial-resistant infections has led to the increase in healthcare expenditure for its treatment and also resulted in rising number of deaths. For instance, according to Centers for Disease Control and Prevention (CDC), in 2019, around 2 Mn people suffer from an antibiotic-resistant infection and at least 23,000 people die each year in the U.S.

According to World Health Organization, in 2016, around 490,000 people suffered globally from multi-drug resistant TB infection.

Moreover, according to the Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India, in 2017, approximately 3.5% of new cases and 18% of previously treated cases of multidrug-resistant tuberculosis were observed in India.

Mrunal Nerkar

The Global Bacteriophage Therapy Market Growth Accelerated By Rising Demand From Healthcare Industry

Dhanesha Patil 2023-12-27

The global Bacteriophage Therapy Market is estimated to be valued at US$ 1280. As new applications are discovered and regulatory hurdles lowered, bacteriophage therapy is poised to accelerate as an indispensable solution in the healthcare industry's fight against antimicrobial resistance. Segment Analysis Bacteriophage Therapy Market is segmented into enteric viruses, lytic bacteriophages and lysogenic bacteriophages. The global Bacteriophage Therapy Market is estimated to be valued at US$ 1280. Regional analysis: North America region currently dominates the bacteriophage therapy market and is expected to continue its dominance during the forecast period. , Tereos Syral are some of the key players operating in the Bacteriophage Therapy Market.

The Global Bacteriophage Therapy Market Growth Accelerated By Use Of Viruses To Fight Bacterial Infections

kiran gire 2024-01-10

The demand for bacteriophage therapy has grown in recent years due to the rise of antibiotic-resistant "superbugs" and need for novel treatment options. The global Bacteriophage Therapy Market is estimated to be valued at US$ 1280. As antibiotic resistance continues to rise globally, bacteriophage therapy is gaining more attention from healthcare practitioners and investors. Segment Analysis The global bacteriophage therapy market is segmented based on product type, application, end-user, and geography. The global Bacteriophage Therapy Market is estimated to be valued at US$ 1280. The company is conducting various research activities and clinical trials to evaluate the efficacy of bacteriophage therapy.

Bacteriophage Therapy is expected to expand a phenomenal growth from assessment period of 2023-2030

Saya Bonde 2023-02-08

The idea behind this approach is to use the specificity of bacteriophages to target and kill specific bacteria, avoiding the general destruction of beneficial bacteria and the development of antibiotic resistance. The rise of antibiotic-resistant bacteria has made conventional antibiotics less effective, leading to a growing interest in alternative therapies such as bacteriophage therapy. This approach to treatment uses viruses (bacteriophages) to target and kill specific bacteria, making it a potential alternative to antibiotics. With the increasing problem of antibiotic resistance, bacteriophage therapy has gained a lot of attention in recent years. The increasing prevalence of bacterial infections and the spread of antibiotic-resistant bacteria have made bacteriophage therapy a promising solution in the fight against infectious diseases.

Bacteriophage Therapy Market Report 2022-2028 | Industry Analysis By Top Key Players

Sofia Kausar 2022-06-03

This report on Bacteriophage Therapy Market mentions the latest trends, growth prospects and global forecast for the upcoming years. The financial analysis, new products launch and other latest development of the top Bacteriophage Therapy market players help in assessing the competitive scenario of the industry. The entire bacteriophage therapy market has been sub-categorized into targeted bacteria and route of administration. Request a FREE Sample Copy of Global Bacteriophage Therapy Market Report with Full TOC At: https://www. Browse Full Global Bacteriophage Therapy Market Research Report With TOC At: https://www.

Bacteriophage Therapy Market Demand Analysis, Statistics, Industry Trends And Investment Opportunities To 2027

Anaya sen 2021-04-03

It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the bacteriophage therapy market include Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, and ContraFect Corporation.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Bacteriophage Therapy Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/bacteriophage-therapy-market/download-sampleMarket DynamicsThe factors that are driving the global bacteriophage market are the increasing prevalence of air, water, and foodborne bacterial infection, and increasing incidences of antibiotic resistance.

This factor is supporting the global market.

Moreover, extensive R & D on bacteriophage therapy by private as well as government sectors is further fuelling the global market.

During the COVID-19 pandemic, the bacteriophage therapy market is likely to expand as the entire global focus is on the development of new treatment therapies for infections.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.

The Bacteriophage Therapy Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Antibiotic-Resistant Infections & Growing Investments in Research and Development

Rahul Kumar Yadav 2023-08-14

A) Market Overview:The global Bacteriophage Therapy Market is estimated to be valued at US$1,148. It has shown promising results in treating antibiotic-resistant infections such as MRSA, E. Firstly, the increasing prevalence of antibiotic-resistant infections is propelling the demand for alternative treatments. 7% over the forecast period, due to increasing prevalence of antibiotic-resistant infections and growing investments in research and development. With its ability to specifically target bacteria and minimal side effects, bacteriophage therapy holds great potential as an alternative treatment option for antibiotic-resistant infections.

WHO TO FOLLOW